← Back to Search

Proton Beam Therapy

Proton Therapy for Breast Cancer

N/A
Recruiting
Led By Samantha Hedrick, PhD
Research Sponsored by Thompson Cancer Survival Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly assessments over 10 weeks
Awards & highlights

Summary

This trial tests a new technique to reduce skin reactions from proton therapy for breast cancer patients. A CT scan helps guide the protons to the right spot, and Spot Delete prevents the protons from stopping in the skin.

Who is the study for?
This trial is for adults with stage 0, I, II, or III breast cancer who've had a lumpectomy or mastectomy. They must not have prior radiation therapy to the chest, be pregnant/lactating, have certain collagen diseases like scleroderma or active dermatomyositis, Paget's disease of the nipple, Stage IV cancer, severe psychiatric conditions or other health issues that could interfere with treatment.
What is being tested?
The study tests 'Spot Delete' in pencil beam scanning proton therapy for breast cancer patients to see if it reduces skin reactions. It involves using CT scans to guide proton beams and avoid them stopping in the skin which may cause redness.
What are the potential side effects?
While specific side effects are not listed here as this is a technique evaluation rather than drug testing; generally speaking potential side effects might include varying degrees of skin irritation such as redness and soreness at the site where protons enter.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly assessments over 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly assessments over 10 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reduction in Radiation Dermatitis
Secondary study objectives
linear energy transfer (LET) of the proton beam

Find a Location

Who is running the clinical trial?

Thompson Cancer Survival CenterLead Sponsor
3 Previous Clinical Trials
700 Total Patients Enrolled
Samantha Hedrick, PhDPrincipal InvestigatorDirector of Medical Physics
~58 spots leftby Jul 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top